# Peter Schraml

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/peter-schraml/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,401 |
| Field | Renal cell carcinoma treatment |
| h-index | 64 |
| i10-index | 142 |
| Last Known Institution | University Hospital of Zurich |
| OpenAlex ID | https://openalex.org/A5053110552 |
| ORCID iD | https://orcid.org/0000-0002-0087-2744 |
| Works | 220 |

## Researcher papers

- [Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.](https://scholariq.org/papers/epigenetic-inactivation-of-the-rassf1a-3p21-3-tumor-suppressor-gene-in-both/)

## Researcher topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Renal and related cancers](https://scholariq.org/topics/renal-and-related-cancers/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)
- [Cancer, Hypoxia, and Metabolism](https://scholariq.org/topics/cancer-hypoxia-and-metabolism/)

## Researcher university

- [University Hospital Zurich](https://scholariq.org/institutions/university-hospital-zurich/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.